Also found in: Wikipedia.
PTLDPost Transplant Lymphoproliferative Disorder
PTLDPhysical Teardown Logistics Demonstration
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
The abundance of small pilot trials investigating NK adoptive transfer has confirmed that, despite a few instances of infection in the setting of lymphodepleting chemotherapy, this approach is overall feasible and safe, particularly with highly pure infusions of NK cells (to avoid the risk of donor B cell-mediated EBV+ PTLD as likely occurred in one patient) [50].
Abbreviations ATN: Acute tubular necrosis BMI: Body mass index BPAR: Biopsy-proven acute rejection CMV: Cytomegalovirus CNI: Calcineurin inhibitor CsA: Cyclosporine DCD: Donation after circulatory death DGF: Delayed graft function dnDSA: De novo donor specific antibodies DSA: Donor specific antibodies ECD: Expanded criteria donor IRI: Ischemia-reperfusion Injury IL-2RA: Interleukin-2 receptor antagonist L-FABP: L-type fatty acid binding protein MFI: Mean fluorescence intensity MMF: Mycophenolate mofetil NAGL: Neutrophil gelatinase-associated lipocalin OPTN: Organ Procurement and Transplant PRA: Panel reactive antibody PTLD: Posttransplant lymphoproliferative disease rATG: Rabbit antithymocyte globulin (Thymoglobuline).
The incidence of PTLD in adult kidney transplant recipients ranges from 1 to 2.3% [6] and although immunosuppression, as can be seen after a transplant, puts the male patient at a 20 to 50 times greater risk of development of testicular neoplasm [7, 8], testicular lymphoma is still exceedingly rare in this population.
Moreover, it appears that the risks of CMV and PTLD are higher after MVTx, contributing to the less favorable outcomes of MVTx [83].
Posttransplantation lymphoproliferative disorder (PTLD) is not only a recognized complication but also one of the most common malignancies of solid organ transplantation with an incidence between 1% and 3% in transplant recipients.
reported 2 cases of donor origin PTLD who developed monoclonal gammopathy of undetermined significance (MGUS) in a 28-year-old female and an 18-year-old male patient who underwent heart-lung transplantation due to primary pulmonary hypertension [5].
From a differential diagnostic point of view, posttransplant lymphoproliferative disorders (PTLD) [10], posttransplant Epstein Barr Virus- (EBV-) associated smooth muscle neoplasms of the liver [11], and primary or metastatic other solid malignancies in posttransplant setting [8] are the main consideration in our case on clinical grounds.
The first cases of post-transplantation lymphoproliferative disorder (PTLD) were published by Penn et al., in 1969 in five patients who received a living donor kidney transplant (1); and since then, it remains as one of the complications of higher morbidity and mortality associated with solid organ transplantation.
But months later Amelia was admitted back to hospital, where medics diagnosed her with PTLD.
After having the bowel operation Alana was told shortly afterwards that Madison had PTLD, a type of cancer linked to transplants.